Evidence map›Paper›PMID 37646666›Full record

ArticleHaematologica2024

Survival disparities between children and adolescents and young adults for the major subtypes of non-Hodgkin lymphoma in the Netherlands: a large population-based study.

Maya Schulpen, Auke Beishuizen, Martine E D Chamuleau, Avinash G Dinmohamed, Friederike A G Meyer-Wentrup, H Josef Vormoor, Lotte E Van der Wagen, Monique C Minnema, Jan L C Loeffen, Henrike E Karim-Kos

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Maya SchulpenPrincess Máxima Center for pediatric oncology, Utrecht.
Auke BeishuizenPrincess Máxima Center for pediatric oncology, Utrecht.
Martine E D ChamuleauDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC, location VU, Amsterdam.
Avinash G DinmohamedDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC, location VU, Amsterdam, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam.
Friederike A G Meyer-WentrupPrincess Máxima Center for pediatric oncology, Utrecht.
H Josef VormoorPrincess Máxima Center for pediatric oncology, Utrecht, The Netherlands; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht.
Lotte E Van der WagenDepartment of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht.
Monique C MinnemaDepartment of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht.
Jan L C LoeffenPrincess Máxima Center for pediatric oncology, Utrecht.
Henrike E Karim-KosPrincess Máxima Center for pediatric oncology, Utrecht, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht. h.e.karim-kos@prinsesmaximacentrum.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Non-HodgkinAdolescentChildHumansNetherlandsYoung Adult

Identifiers

PMID37646666
PMCPMC10905077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.